Androgen Deprivation Therapy ± Palbociclib in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
A Randomized Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Clin. Cancer Res 2021 Mar 16;[EPub Ahead of Print], PL Palmbos, S Daignault-Newton, SA Tomlins, et alAdvanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.